Sullivan Christopher Ryan
Chief Financial Officer · 19 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-10 | AVTX | Avalo Therapeutics, Inc. | Tax withholding | 138 | $13.10 | $1,807.80 | filing |
| 2026-05-21 | AVTX | Avalo Therapeutics, Inc. | Award | 39,900 | $0.00 | $0.00 | filing |
| 2026-05-07 | AVTX | Avalo Therapeutics, Inc. | Sale | 18,606 | $24.12 | $448,817.65 | filing |
| 2026-05-07 | AVTX | Avalo Therapeutics, Inc. | Option exercise | 18,606 | $9.88 | $183,827.28 | filing |
| 2026-05-06 | AVTX | Avalo Therapeutics, Inc. | Option exercise | 47,000 | $8.04 | $377,880.00 | filing |
| 2026-05-06 | AVTX | Avalo Therapeutics, Inc. | Sale | 13,834 | $18.55 | $256,655.29 | filing |
| 2026-05-06 | AVTX | Avalo Therapeutics, Inc. | Sale | 12,347 | $19.28 | $238,093.37 | filing |
| 2026-05-06 | AVTX | Avalo Therapeutics, Inc. | Sale | 8,900 | $22.57 | $200,913.05 | filing |
| 2026-05-06 | AVTX | Avalo Therapeutics, Inc. | Sale | 9,219 | $21.37 | $197,008.19 | filing |
| 2026-05-06 | AVTX | Avalo Therapeutics, Inc. | Sale | 2,700 | $20.76 | $56,052.00 | filing |
| 2026-04-30 | AVTX | Avalo Therapeutics, Inc. | Sale | 8,457 | $13.23 | $111,853.13 | filing |
| 2026-04-29 | AVTX | Avalo Therapeutics, Inc. | Sale | 8,458 | $13.09 | $110,736.37 | filing |
| 2026-04-02 | AVTX | Avalo Therapeutics, Inc. | Sale | 6,200 | $17.02 | $105,553.14 | filing |
| 2026-04-02 | AVTX | Avalo Therapeutics, Inc. | Sale | 1,780 | $17.57 | $31,269.97 | filing |
| 2026-04-01 | AVTX | Avalo Therapeutics, Inc. | Sale | 7,479 | $16.83 | $125,840.91 | filing |
| 2026-04-01 | AVTX | Avalo Therapeutics, Inc. | Sale | 500 | $15.86 | $7,929.00 | filing |
| 2026-03-28 | AVTX | Avalo Therapeutics, Inc. | Tax withholding | 8,241 | $13.89 | $114,467.49 | filing |
| 2026-03-28 | AVTX | Avalo Therapeutics, Inc. | Option exercise | 24,200 | — | — | filing |
| 2025-12-10 | AVTX | Avalo Therapeutics, Inc. | Tax withholding | 155 | $4.10 | $635.50 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.